Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor

Jun-Hyeok Kang, Joseph J. Noh, Soo Jeong, Jung In Shim, Yoo-Young Lee, Chel Hun Choi, Jeong‐Won Lee, Byoung‐Gie Kim, Duk‐Soo Bae, Hyun Soo Kim, Tae‐Joong KimFrontiers in Oncology 2020 · DOI

TL;DR

This study investigates the feasibility and outcomes of Single-Port Access (SPA) laparoscopy for large ovarian tumors suspected to be borderline ovarian tumors (BOT). The findings suggest SPA laparoscopy is a safe and effective alternative to traditional laparotomy, offering comparable oncological outcomes with reduced perioperative complications and shorter hospital stays.

What Problem Does This Paper Address?

Borderline ovarian tumors (BOTs) represent a unique category of ovarian neoplasms, falling between benign and malignant tumors. While generally having a favorable prognosis, they can recur and, in rare cases, metastasize. Standard surgical treatment involves complete staging, similar to malignant ovarian cancer. However, the increasing adoption of minimally invasive surgery (MIS) has led to questions about its applicability to larger BOTs, particularly concerning the potential for tumor spillage and the adequacy of intraoperative frozen section (FS) analysis. Surgeons often hesitate to use SPA laparoscopy for large tumors due to these concerns, preferring traditional laparotomy despite its higher morbidity. This paper aims to address this gap by comparing the surgical, pathological, and oncological outcomes of SPA laparoscopy versus laparotomy for large BOTs (>15 cm).

Methods

The study employed a retrospective review of 178 patients who underwent surgical treatment for large ovarian tumors suspected to be BOT. Patients were divided into two groups: those who underwent Single-Port Access (SPA) laparoscopy (n=105) and those who underwent laparotomy (n=73). The researchers compared various outcomes, including:

  • Surgical Outcomes: Operation time, estimated blood loss (EBL), intraoperative spillage of tumor contents, perioperative complications (ileus, wound complications), hospital stay duration, and conversion rates to multiport laparoscopy or laparotomy.
  • Pathological Outcomes: The accuracy and reliability of intraoperative frozen section (FS) analysis compared to permanent pathology results, including rates of under-diagnosis and over-diagnosis.
  • Oncological Outcomes: Recurrence-free survival (RFS) and overall survival (OS) for patients diagnosed with BOT or malignant tumors.

The surgical technique for SPA involved a small umbilical incision, insertion of a wound retractor, and the use of specialized instruments. Tumor removal was often facilitated by extracorporeal aspiration and morcellation within an endo-pouch.

Datasets

The study utilized data from patients treated at Samsung Medical Center in Seoul, South Korea, between January 2015 and December 2018. The dataset included patient demographics, tumor characteristics (size, serum tumor markers like CA-125 and CA 19-9), surgical approach, intraoperative findings, and histopathological results. No new datasets were introduced.

Key Insights and Ideas

  • SPA is Viable for Large BOTs: Contrary to the common surgical hesitation, SPA laparoscopy proved to be a feasible and safe approach even for large ovarian tumors (mean diameter > 20 cm) suspected to be BOT.
  • Reduced Morbidity with SPA: SPA laparoscopy was associated with significantly fewer postoperative complications and a shorter hospital stay compared to laparotomy, highlighting its advantage in patient recovery.
  • Comparable Oncological Outcomes: Crucially, SPA laparoscopy did not compromise oncological outcomes. Recurrence-free survival and overall survival rates were similar between the SPA and laparotomy groups for both BOT and malignant tumors.
  • Spillage Not a Differentiator: While concerns about tumor spillage are common with laparoscopic approaches, this study found no significant difference in the rates of iatrogenic spillage between SPA laparoscopy and laparotomy. This suggests that careful technique in SPA can mitigate this risk.
  • FS Accuracy is Consistent: The accuracy of intraoperative frozen section analysis was not significantly affected by the surgical approach, indicating that surgeons can rely on FS findings for intraoperative decision-making regardless of whether they choose SPA or laparotomy.

Key Results

  • Patient Cohort: 178 patients were included, with 105 in the SPA group and 73 in the laparotomy group.
  • Tumor Size: Mean tumor diameter was comparable between groups (20.9 cm for SPA vs. 20.2 cm for laparotomy).
  • Operation Time: No significant difference in mean operation time (99.1 min for SPA vs. 107.3 min for laparotomy, p=0.085).
  • Spillage: Similar rates of iatrogenic spillage (11.4% in SPA vs. 6.8% in laparotomy, p=0.381).
  • Postoperative Complications: Significantly higher in the laparotomy group (20.5%) compared to the SPA group (5.7%, p=0.025).
  • Hospital Stay: Shorter in the SPA group (2 days) compared to the laparotomy group (5 days, p=0.041).
  • FS Accuracy: Overall agreement between FS and final pathology was 78.0%. Misdiagnosis rates did not differ between groups.
  • Survival: No significant difference in recurrence-free survival or overall survival between the SPA and laparotomy groups for BOT or malignant tumors.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Study Design: This limits the ability to establish causality and may introduce selection bias.
  • Lack of Pathological Review: The study did not include a dedicated pathological review, which could have identified inaccuracies in diagnoses.
  • No Pain/Cosmetic Outcome Evaluation: While SPA is known for better cosmetic outcomes and potentially less pain, these were not formally assessed.
  • Tertiary Center Expertise: SPA laparoscopy for large tumors is primarily performed in specialized centers by experienced surgeons, limiting generalizability.
  • Subjective Spillage Assessment: Spillage was assessed by gross observation of cystic wall rupture, not by cytologic confirmation.

Future research could focus on prospective studies to confirm these findings, incorporate objective measures of pain and cosmetic outcomes, and explore the role of robotic-assisted single-port surgery for large ovarian tumors.

Summary updated

Abstract

SPA laparoscopy is feasible, safe, and not inferior to laparotomy for surgical treatment of large ovarian tumors that suspected to be BOT on preoperative imaging.
BibTeX
@inproceedings{kang2020feasibility,
  author = {Jun-Hyeok Kang and Joseph J. Noh and Soo Jeong and Jung In Shim and Yoo-Young Lee and Chel Hun Choi and Jeong‐Won Lee and Byoung‐Gie Kim and Duk‐Soo Bae and Hyun Soo Kim and Tae‐Joong Kim},
  title = {{Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor}},
  booktitle = {Frontiers in Oncology},
  year = {2020},
  doi = {10.3389/fonc.2020.583515},
}
Figure